Allen Davidoff

Company: XORTX Therapeutics Inc.

Job title: President & Chief Executive Officer

Seminars:

Intersection of Emerging Genetic Evidence for Accelerated Disease Progression & a Late-Stage Clinical Candidate for a Novel Preclinical Candidate for Rare & Genetic Kidney Disease 10:30 am

Discovering the genetic background and new alleles influencing ADPKD Demonstrating aberrant purine metabolism and exploring preclinical model data Discussing the path forwardRead more

day: Conference Day Two